Maya Charafeddine

About Maya Charafeddine

Maya Charafeddine, With an exceptional h-index of 18 and a recent h-index of 17 (since 2020), a distinguished researcher at American University of Beirut,

His recent articles reflect a diverse array of research interests and contributions to the field:

Genomic profiling of bladder cancer in waterpipe and cigarette smokers: Implications for carcinogenicity and genetic landscape.

Improved survival of young patients with breast cancer 40 years and younger at diagnosis

Colorectal Cancer Screening in the Middle East: What, Why, Who, When, and How?

Timing of cyclosporine administration for GvHD prophylaxis in haploidentical stem cell transplantation setting: Single center experience

Can plasma vitamin C predict survival in stage IV colorectal cancer patients? Results of a prospective cohort study

Breast cancer knowledge in Lebanese females with positive family history

Quality-of-life outcomes after total neoadjuvant short course radiotherapy, chemo-immunotherapy, and total mesorectal excision for locally advanced rectal cancer.

Assessment of immunoscore and MRI tumor regression grade to predict complete pathologic response in patients with locally advanced rectal cancer: Data from phase II Averectal …

Maya Charafeddine Information

University

Position

___

Citations(all)

1824

Citations(since 2020)

979

Cited By

1167

hIndex(all)

18

hIndex(since 2020)

17

i10Index(all)

25

i10Index(since 2020)

23

Email

University Profile Page

Google Scholar

Top articles of Maya Charafeddine

Genomic profiling of bladder cancer in waterpipe and cigarette smokers: Implications for carcinogenicity and genetic landscape.

2024/2/1

Improved survival of young patients with breast cancer 40 years and younger at diagnosis

JCO Global Oncology

2023/5

Maya Charafeddine
Maya Charafeddine

H-Index: 13

Hazem Assi
Hazem Assi

H-Index: 12

Colorectal Cancer Screening in the Middle East: What, Why, Who, When, and How?

American Society of Clinical Oncology Educational Book

2023/5

Ali Shamseddine
Ali Shamseddine

H-Index: 26

Maya Charafeddine
Maya Charafeddine

H-Index: 13

Timing of cyclosporine administration for GvHD prophylaxis in haploidentical stem cell transplantation setting: Single center experience

Current research in translational medicine

2023/4/1

Maya Charafeddine
Maya Charafeddine

H-Index: 13

Can plasma vitamin C predict survival in stage IV colorectal cancer patients? Results of a prospective cohort study

Frontiers in Nutrition

2023/3/6

Breast cancer knowledge in Lebanese females with positive family history

Medicine

2023/2/17

Maya Charafeddine
Maya Charafeddine

H-Index: 13

Quality-of-life outcomes after total neoadjuvant short course radiotherapy, chemo-immunotherapy, and total mesorectal excision for locally advanced rectal cancer.

2023/2/1

Ali Shamseddine
Ali Shamseddine

H-Index: 26

Maya Charafeddine
Maya Charafeddine

H-Index: 13

Assessment of immunoscore and MRI tumor regression grade to predict complete pathologic response in patients with locally advanced rectal cancer: Data from phase II Averectal …

2023/2/1

Ali Shamseddine
Ali Shamseddine

H-Index: 26

Maya Charafeddine
Maya Charafeddine

H-Index: 13

Preferences for the sequencing of first-line systemic treatments in metastatic hormone receptor-positive, HER2-negative breast cancer

Frontiers in Oncology

2023

Maya Charafeddine
Maya Charafeddine

H-Index: 13

PO119 SURVIVAL OF YOUNG PATIENTS WITH ADVANCED BREAST CANCER STAGES III AND IV

The Breast

2023/10/1

CT-629 The Impact of Maintenance Therapy Post Allogeneic Hematopoietic Cell Transplantation on Survival Outcomes in Patients Diagnosed With Acute Myeloid Leukemia and …

Clinical Lymphoma Myeloma and Leukemia

2023/9/1

Maya Charafeddine
Maya Charafeddine

H-Index: 13

Iman Abou Dalle
Iman Abou Dalle

H-Index: 8

Maintenance chemotherapy in advanced and metastatic pancreatic cancer, a narrative review and case series

2023/8

P-106 The neoadjuvant rectal (NAR) score application in the context of total neoadjuvant treatment with chemo-immuno-radiation for locally advanced rectal cancer: Data from the …

Annals of Oncology

2023/6/1

P-88 Epithelial-to-mesenchymal transition: An emerging prognostic tool in resectable pancreatic cancer, a retrospective study

Annals of Oncology

2023/6/1

Well-differentiated gastro-entero-pancreatic neuroendocrine tumors with positive FDG-PET/CT: a retrospective chart review

Nuclear Medicine Communications

2023/6/1

Maya Charafeddine
Maya Charafeddine

H-Index: 13

Ali Shamseddine
Ali Shamseddine

H-Index: 26

Pathogenic mutations in ethnic Lebanese Arab patients with high risk for hereditary breast cancer

European Journal of Cancer

2022/11/1

P-279 A rare subset of well-differentiated gastro-entero-pancreatic neuroendocrine tumors with positive FDG PET/CT: Is it a sign of an aggressive disease?

Annals of Oncology

2022/6/1

P-258 Chemoimmunotherapy in the context of total neoadjuvant therapy (TNT) in patients with locally advanced rectal cancer

Annals of Oncology

2022/6/1

P-274 The prognostic significance of early expression of epithelial-to-mesenchymal transition markers in resectable pancreatic cancer patients

Annals of Oncology

2022/6/1

P-276 Maintenance chemotherapy in advanced and metastatic pancreatic cancer, a case series

Annals of Oncology

2022/6/1

See List of Professors in Maya Charafeddine University(American University of Beirut)